Loading data
CRWDNasdaq
| Unit: USD | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| Cost of revenue | 1.22 bn USD | 990.17 m USD | 758.93 m USD | 601.23 m USD | 383.22 m USD |
| Gross profit | 3.59 bn USD | 2.96 bn USD | 2.3 bn USD | 1.64 bn USD | 1.07 bn USD |
| Research and development expense | 1.38 bn USD | 1.08 bn USD | 780.32 m USD | 608.36 m USD | 371.28 m USD |
| Operating profit | -293.29 m USD | -116.4 m USD | -19.14 m USD | -190.11 m USD | -142.55 m USD |
| Interest expense | — | — | 25.76 m USD | 25.32 m USD | 25.23 m USD |
| Profit before tax | -126.99 m USD | 58.56 m USD | 105.67 m USD | -159.88 m USD | -160.02 m USD |
| Income tax expense | 34.18 m USD | 71.1 m USD | 32.2 m USD | 22.4 m USD | 72.36 m USD |
| Net income (reported basis) | -161.17 m USD | -12.57 m USD | 73.44 m USD | -182.29 m USD | -232.38 m USD |
| Basic earnings per share | -0.65 USD/share | -0.06 USD/share | 0.3 USD/share | -0.79 USD/share | -1.03 USD/share |
| Diluted earnings per share | -0.65 USD/share | -0.06 USD/share | 0.3 USD/share | -0.79 USD/share | -1.03 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.